22594-28-1

Basic information

• Product Name: Methyl 4-amino-4,6-dideoxy-α-L-mannopyranoside
• Synonyms: Methyl 4-amino-4,6-dideoxy-α-L-mannopyranoside
• CAS NO: 22594-28-1
• Molecular Formula: C₇H₁₅NO₄
• Molecular Weight: 177.1983
• Mol File: 22594-28-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 4-amino-4,6-dideoxy-α-L-mannopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-amino-4,6-dideoxy-α-L-mannopyranoside(22594-28-1)
• EPA Substance Registry System: Methyl 4-amino-4,6-dideoxy-α-L-mannopyranoside(22594-28-1)

Safety Data

• Hazardous Substances Data: 22594-28-1(Hazardous Substances Data)

Upstream product

• 116249-66-2 pradimicin C 
• 139285-80-6 methyl 6-deoxy-2,3-O-isopropylidene-4-O-(trifluoromethylsulfonyl)-α-L-talopyranoside 
• 18719-97-6 methyl 6-deoxy-2,3-O-isopropylidene-α-L-talopyranoside 
• 24562-43-4 methyl 6-deoxy-2,3-O-isopropylidene-α-L-talopyranoside 
• 2592-53-2 methyl 6-deoxy-2,3-O-isopropylidene-α-L-lyxo-hexopyranoside-4-ulose 
• 22594-27-0 methyl 4-azido-4-deoxy-α-L-rhamnopyranoside 

Relevant articles and documents

Synthesis and biological evaluation of enantiomeric rhamnose analogues of the antitumour agent spicamycin - Is the mode of action by modification of N-linked glycoproteins?

The synthesis of both enantiomers of dodecyl rhamnospicamycin 2a and 2b, a rhamnose analogue of the naturally occurring combinatorial library spicamycin 1, are derived from L-rhamnose and methyl α-D-mannopyranoside, respectively. The L-(+)-enantiomer 2a c

Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B

The structures of tallysomycins A and B, two major components of a new antitumor antibiotic complex, have been determined. They are glycopeptide antibiotics structurally related to bleomycin: four amino acid moieties and a disaccharide fragment which are the constituents of bleomycin molecule are also present in the tallysomycins. Tallysomycins A and B contain two new amino acids and a unique amino sugar, 4-amino-4,6-dideoxy-L-talose, which have not been hitherto found in the phleomycin-bleomycin group of antibiotics. In addition tallysomycin A has an additional amino acid, L-β-lysine, and thus a longer peptide chain than bleomycin or tallysomycin B. Tallysomycins A and B have the same terminal amine moiety, spermidine.